Risk for Zoster Up Before Diagnosis, During Treatment of Hematologic Cancer

MONDAY, Dec. 17, 2018 -- The risk for herpes zoster (zoster) is elevated during the two years preceding diagnosis and during treatment of hematological cancer, according to a study published online Dec. 13 in the Journal of Infectious...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news